Defining multiple sclerosis disease activity using MRI T2-weighted difference imaging

Brain

Volumn 121, Issue 11, 1998, Pages 2095-2102

  Lee, M A ^a,b   Smith, S ^a   Palace, J ^b   Matthews, P M ^a,b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Difference images; MRI; Multiple sclerosis

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; HUMAN; IMAGE ENHANCEMENT; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PRIORITY JOURNAL;

ADULT; BRAIN; DISEASE PROGRESSION; FEMALE; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RECURRENCE; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC;

EID: 0031793235     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/121.11.2095     Document Type: Article

References (27)

1. Collins DL, Neelin P, Peters TM and Evans AC. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 1994; 18: 192-205.
2. Filippi M, Horsfield MA, Tofts PS, Barkhof F, Thompson AJ, Miller DH. Quantitative assessment of MRI lesion load in monitoring the evolution of multiple sclerosis. [Review]. Brain 1995; 118: 1601-12.
3. Grimaud J, Lai M, Thorpe J, Adeleine P, Wang L, Barker GJ et al. Quantitation of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques. Magn Reson Imaging 1996; 14: 495-505.
4. Hajnal JV, Saeed N, Oatridge A, Williams EJ, Young IR, Bydder GM. Detection of subtle brain changes using subvoxel registration and subtraction of serial MR images. J Comput Assist Tomogr 1995; 19: 677-91.
5. Kappos L, Stadt D, Ratzka M, Keil W, Schneiderbanger-Grygier S, Heitzer T, et al. Magnetic resonance imaging in the evaluation of treatment in multiple sclerosis. Neuroradiology 1988; 30: 299-302.
6. Kastrukoff LF, Oger JJ, Hashimoto SA, Sacks SL, Li DK, Palmer MR, et al. Systemic lymphoblastoid interferon therapy in chronic progressive multiple sclerosis. 1. Clinical and MRI evaluation. Neurology 1990; 40: 479-86.
7. Katz D, Taubenberger JK, Cannella B, McFarlin DE, Raine CS, McFarland HF. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 1993; 34: 661-9.
8. Khoury SJ, Guttmann CR, Orav EJ, Hohol MJ, Ahn SS, Hsu L, et al. Longitudinal MRI in multiple sclerosis: correlation between disability and lesion burden. Neurology 1994; 44: 2120-4.
9. Koudriavtseva T, Thompson AJ, Fiorelli M, Gasperini C, Bastianello S, Bozzao A, et al. Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 1997; 62: 285-7.
10. Kurtzke J. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983; 33: 1444-52.
11. Lee M, Palace J, Narayanan S, Arnold DL, Matthews PM. Lesion probability mapping for characterisation of the spatial dynamics of disease activity in multiple sclerosis [abstract]. J Neurol 1997; 244 Suppl 2: S37-8.
12. McFarland HF, Frank JA, Albert PS, Smith ME, Martin R, Harris JO, et al. Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol 1992; 32: 758-66.
13. Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines [see comments]. J Neurol Neurosurg Psychiatry 1991; 54: 683-8. Comment in: J Neurol Neurosurg Psychiatry 1992; 55: 978.
14. Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ. Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines [see comments]. J Neurol Neurosurg Psychiatry 1991; 54: 683-8. Comment in: J Neurol Neurosurg Psychiatry 1992; 55: 978.
15. Miller DH, Barkhof F, Nauta JJ. Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. Brain 1993; 116: 1077-94.
16. Miller DH, Albert PS, Barkhof F, Francis G, Frank JA, Hodgkinson S, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force. Ann Neurol 1996; 39: 6-16.
17. Miller DH, Kesselring J, McDonald WI, Paty DW, Thompson AJ. Magnetic resonance in multiple sclerosis. Cambridge: Cambridge University Press; 1997.
18. Molyneux PD, Filippi M, Barkhof F, Gasperini C, Yousry TA, Truyen L, et al. Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis. Ann Neurol 1998; 43: 332-9.
19. Nesbit GM, Forbes GS, Scheithauer BW, Okazaki H, Rodriguez M. Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology 1991; 180: 467-74.
20. Paty DW, Li DK, the UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial [see comments]. Neurology 1993; 43: 662-7. Comment in: Neurology 1993; 43: 641-3.
21. Paty DW, Li DK, the UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial [see comments]. Neurology 1993; 43: 662-7. Comment in: Neurology 1993; 43: 641-3.
22. Stone LA, Albert PS, Smith ME, DeCarli C, Armstrong MR, McFarlin DE, et al. Changes in the amount of diseased white matter over time in patients with relapsing-remitting multiple sclerosis. Neurology 1995; 45: 1808-14.
23. Storch M, Lassmann H. Pathology and pathogenesis of demyelinating diseases. [Review]. Curr Opin Neurol 1997; 10: 186-92.
24. Strother SC, Anderson JR, Xu XL, Liow JS, Bonar DC, Rottenberg DA. Quantitative comparisons of image registration techniques based on high-resolution MRI of the brain. J Comput Assist Tomogr 1994; 18: 954-62.
25. Whitaker NJ, McFarland HF, Rudge P, Reingold SC. Outcomes assessment in multiple sclerosis clinical trials: a critical analysis. Mult Scler 1995; 1: 37-47.
26. Willoughby EW, Grochowski E, Li DK, Oger J, Kastrukoff LF, Paty DW. Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients. Ann Neurol 1989; 25: 43-9.
27. Wong JCH, Studholme C, Hawkes DJ, Maisey MN. Evaluation of the limits of visual detection of image misregistration in a brain fluorine-18 fluorodeoxyglucose PET-MRI study. Eur J Nucl Med 1997; 24: 642-50.